Exploring new treatments for Fuchs' endothelial corneal dystrophy
Official title: Unlocking Corneal Endothelial Regeneration: Novel Therapeutic Strategies for Fuchs' Endothelial Corneal Dystrophy
Funded at University of Pennsylvania · NIH-11171537 · Data updated 2026-11-12
This study is looking at ways to help people with Fuchs' endothelial corneal dystrophy, a condition that can cause vision problems, by finding out how to encourage the growth of healthy corneal cells to improve their eyesight.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | September 1, 2024 |
| Project end | April 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $709,979 |
| NIH project number | 5R01EY036440-02 |
| Project ID | NIH-11171537 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Fuchs' endothelial corneal dystrophy, particularly those experiencing vision impairment due to the condition.
✕Less likely to help
Patients with other types of corneal diseases or those who do not have Fuchs' endothelial corneal dystrophy may not benefit from this research.
What this research studies
This research investigates the potential for regenerating corneal endothelial cells (CECs) in patients with Fuchs' endothelial corneal dystrophy (FECD), a condition that leads to vision loss. The team will use advanced imaging techniques and genetic mouse models to understand how CECs can be stimulated to proliferate and restore corneal health. By identifying the molecular mechanisms behind CEC regeneration, the researchers aim to develop innovative therapies that could improve vision for affected individuals.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that restore vision in patients suffering from Fuchs' endothelial corneal dystrophy.
How similar studies have gone: While the approach of stimulating corneal endothelial cell regeneration is innovative, similar regenerative strategies have shown promise in other ocular conditions, suggesting potential for success.
Where this research is happening
-
University of Pennsylvania
Philadelphia, United States Active
Researchers
- Principal investigator: Rompolas, Panteleimon — University of Pennsylvania
- Study coordinator: Rompolas, Panteleimon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.